A retrospective study assessing the tolerability and efficacy of CBD-rich cannabis in children with ASD.

KEY RESULTS:

• Considerable improvement was reported in behavior (61%), communication (47%), and anxiety (39%), after at least 3 months of cannabis treatment
• 33% of children reduced their other medication doses and 24% stopped taking medications altogether

STRAINS: Avidekel and other CBD-rich cannabis oil at a 20:1 (CBD:THC) ratio

STUDY POPULATION:
60 children with ASD and severe behavioral problems